Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Feasibility of an Early Home-based Cycling Intervention After Knee Arthroplasty

NCT07838012 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2026-09-21
Last updated
2026-10-02

Condition(s) studied

Knee OsteoarthritisKnee Arthroplasty

Investigational drug(s) / intervention(s)

Early home-based stationary cyclingUsual care: home-based exercise programme

Early home-based stationary cycling: Participants will receive individual instruction in the cycling protocol from a physiotherapist in addition to the standard postoperative home-based exercise programme described for the control group. Beginning two weeks after knee arthroplasty, participants will perform 30 minutes of home-based stationary cycling at least five days per week for eight weeks. Cycling will initially be performed at a comfortable pace with no resistance and a cadence of approximately 50-60 rpm, with cadence and resistance gradually increasing as tolerated. If unable to complete full pedal rotations, participants will perform pendulum exercises twice daily for five minutes until sufficient knee flexion is achieved. A traffic-light symptom guide will be used to adjust cycling according to pain and swelling. Participants will not be routinely referred to supervised rehabilitation during the intervention period but may contact the physiotherapy team for advice or attend a consultation if clinically indicated.

Usual care: home-based exercise programme: Participants will follow the standard post-operative home-based exercise programme, consisting of five exercises targeting knee range of motion and quadriceps strength, performed twice daily. At the two-week post-operative follow-up, participants will receive instruction in a second exercise programme. The exercises prescribed will be individually adjusted by a physiotherapist according to the participant's recovery and readiness for progression, including knee range of motion, functional capacity, and pain. Participants will not be routinely referred to supervised rehabilitation during the intervention period but may contact the physiotherapy team for advice or attend an additional consultation if clinically indicated.

Study summary

The goal of this pilot clinical trial is to evaluate whether an early, home-based stationary cycling programme, provided in addition to standard postoperative home exercises, is feasible and acceptable for patients recovering from knee arthroplasty. It will also inform the design of a larger clinical trial examining the effects of adding early cycling to standard postoperative home exercises on postoperative outcomes.

The main questions it aims to answer are:

* Can the cycling programme and planned study procedures be delivered as intended?
* Are participants willing and able to take part in the study and follow the planned interventions?
* Do participants find the cycling programme and outcome assessments acceptable?
* What changes, if any, are needed before conducting a larger clinical trial?

Researchers will compare an early home-based stationary cycling programme provided in addition to standard postoperative home exercises with standard postoperative home exercises alone.

Participants will:

* Be randomly assigned to either the cycling group or the standard exercise group (control group) two weeks after surgery.
* If assigned to the cycling group, perform 30 minutes of stationary cycling at home at least five days per week for eight weeks in addition to the standard postoperative home exercise programme.
* If assigned to the control group, follow the standard postoperative home exercise programme and refrain from structured cycling during the eight-week intervention period.
* Complete questionnaires and physical assessments at baseline and follow-up visits.
* Complete selected patient-reported outcome measures at 6 and 12 months after surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Scheduled for unilateral primary medial unicompartmental knee arthroplasty (UKA) or total knee arthroplasty (TKA). * Age ≥ 18 years. * Able to speak and read Danish. * Daily access to a stationary bike during the intervention period, or willingness to use a stationary bike provided by the study through an external rental company for the duration of the intervention. Due to logistical constraints, loan bikes can only be provided to participants residing within approximately one hour of transport from Aarhus or Silkeborg. Participants living outside this area may participate if they have access to a stationary bike. * Ability to use a smartphone with internet connectivity (required for completion of electronic questionnaires and using SENS motion application) or a tablet and having an email address enabling completion of electronic questionnaires. Exclusion Criteria: * Previous surgery in either lower limb within 3 months before the date of knee arthroplasty or planned surgery in either lower limb within 3 months after the date of knee arthroplasty. * Inflammatory joint disease * Previous osteotomy around the knee or tibial condyle fracture that has been treated with osteosynthesis in the affected knee. * Medical or physical conditions that would prevent safe participation in the cycling intervention (e.g., unstable cardiovascular, pulmonary, or chronic neurodegenerative disorders). * Active cancer treatment, if this treatment would interfere with safe participation or adherence to the cycling protocol. * Preoperative reduced knee flexion preventing full pedal rotation on a stationary bike. * Current or recent history of alcohol and/or substance misuse, as identified during the anaesthetic pre-assessment and documented in the electronic patient record. * Cognitive impairment (e.g. dementia) or diagnosed psychiatric disorder that would prevent the patient from understanding or adhering to the cycling protocol.

Primary outcome measure(s)

  • Screening and eligibility rate — From study initiation until completion of recruitment.
    The number of patients screened per week and the proportion who are eligible.
  • Recruitment rate — From study initiation until completion of recruitment.
    Number of eligible patients providing verbal agreement to participate per week and proportion of eligible patients providing verbal agreement to participate.
  • Declined participation among eligible patients — From study initiation until completion of recruitment.
    Number and proportion of eligible patients who decline participation after receiving study information.
  • Baseline assessment completion — At baseline, before randomisation
    Proportion of participants who provide written informed consent and complete the planned baseline assessment before randomisation. Completion of individual objective and physical performance assessments will also be recorded to identify any assessments that are not completed.
  • Retention and completion of 10-week follow-up assessments — 10 weeks after surgery
    Proportion of randomised participants who attend the 10-week follow-up assessment and proportion who complete all planned objective and physical performance assessments, reported separately for the intervention and control groups. Reasons for non-attendance and incomplete assessments will also be recorded.
  • Adherence to the cycling intervention — 2 to 10 weeks after surgery.
    Objective adherence to the prescribed cycling intervention, including frequency and duration of cycling sessions and the proportion of prescribed cycling days completed, assessed using the SENS Motion® sensor system.
  • Cycling-related pain, swelling and discomfort — Approximately 1-2 weeks after initiation of the cycling intervention.
    Participant-reported pain, swelling and discomfort related to cycling, assessed during a structured telephone assessment approximately one week after initiation of the cycling intervention. Responses will be recorded descriptively. Participants unable to complete full pedal rotations will be contacted again one week later.
  • Acceptability of the cycling intervention — 10 weeks after surgery.
    Participant-reported acceptability of the home-based cycling intervention assessed using selected items from the Theoretical Framework of Acceptability (TFA) questionnaire. The items assess affective attitude, burden, perceived effectiveness, self-efficacy, and overall acceptability. Responses are recorded on five-point Likert scales.
  • Completion of patient-reported outcome measures — Baseline and 10 weeks after surgery
    Proportion of participants who complete all planned patient-reported outcome measures (PROMs) at baseline and 10-week follow-up. Completion of individual PROMs and missing questionnaire items will also be recorded to identify PROMs with incomplete data.
  • Participant-reported burden of outcome assessments — Baseline and 10 weeks after surgery
    Participant-reported burden of the questionnaires and objective assessments, assessed using two yes/no questions on whether the assessments were so burdensome that the participant would choose not to participate in a similar study again. Participants answering "yes" will be asked to provide a brief reason.
  • Adverse events and postoperative complications — From randomisation to 10 weeks after surgery.
    Adverse events and postoperative complications reported by participants or identified in electronic health records during the study period. Events will be recorded and summarised descriptively.

Trial sites (1)

FacilityCityRegionStatus
Regional Hospital Silkeborg Silkeborg Central Jutland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07838012 on ClinicalTrials.gov ↗ ← All trials in Denmark